|
|
||||||||
J Thorac Cardiovasc Surg 2006;131:478-479
© 2006 The American Association for Thoracic Surgery
Brief Communication |
a Loyola University Stritch School of Medicine, Chicago
b Christ Medical Center, Department of Pathology, Oak Lawn, Ill
c The Heart Institute for Children, Hope Children Hospital, Oak Lawn, Ill
Received for publication June 30, 2005; revisions received September 28, 2005; accepted for publication September 29, 2005. * Address for reprints: Jeffrey H. Shuhaiber, MD, Department of Surgery, Loyola University Stritch School of Medicine, 614-G Laflin, Chicago, IL 60612 (Email: jeffrey01{at}mac.com).
Clinical Summary
A 4
-year-old child with hypoplastic left heart syndrome had successfully undergone stage 3 surgical palliation. Dilatation of the neoaorta (28 mm) was first noticed 24 months after a stage 1 Norwood procedure. Progressive enlargement was documented by serial echocardiographic evaluation. At pre-Fontan cardiac catheterization the neoaorta was 32 mm at the mid-ascending level and the pulmonary valve (neoaortic valve) was 27 mm with mild-to-moderate insufficiency. Four months after the extracardiac Fontan procedure the child had syncopal episodes during exercise associated with pallor and weakness. Thorough neurologic evaluation was unrevealing. Holter monitor recordings and electrophysiologic studies were essentially negative except for mild sick sinus syndrome with no inducible arrhythmias. Hematologic work-up was within normal limits. Cardiac catheterization showed complete occlusion of the left pulmonary artery and interval growth of the aneurysm to 55 mm (23 mm increase) in diameter over 20 months (Figure 1, A and B). Follow-up cardiac catheterization after 1 month of warfarin sodium (Coumadin) and aspirin therapy revealed complete recanalization of the occluded pulmonary artery yet persistent compression by the neoaortic aneurysm. Thrombophilia work-up was within normal limits. The patient underwent successful stent placement of the left pulmonary artery to optimize pulmonary flow. Despite stenting, he continued to have symptoms. Therefore, in the presence of a growing symptomatic neoaortic aneurysm, a decision for definitive surgical management was made.
|
|
Microscopic examination of tissues stained with hematoxylin and eosin, elastic, trichrome, and alcian blue stains revealed portions of aortic and graft wall including suture remnants. There was no evidence of inflammation, pseudoaneurysm formation, or dissection. Disruption of numerous elastic laminae with parallel arrangement and foci of fibrointimal proliferation were visualized in the vicinity of the pericardial patchnative great vessel anastomosis. Some elastic laminae separated by pale myxoid material suggested foci of cystic medial degeneration (Figure 2, A and B).
|
Various problems not infrequently seen in patients after stage 1 surgery include distortion of the central pulmonary artery and pulmonary valve incompetence.
1
However, aneurysmal dilation of the neoaorta is rare.
There has been one report of aneurysm formation of the neoaorta.
2
The authors suggested that both neoaortic regurgitation and aneurysm formation were probably related to the homograft patch material used, the pulmonary valve, and its sinotubular component, or a combination of these factors. Although in our case we did observe diffuse aneurysmal formation of the ascending neoaorta, there were numerous elastic disruptions of elastic laminae with parallel arrangement containing foci of fibrointimal proliferation. The lack of excessive accumulation of myxoid extracellular matrix in this homograft, as reported by Ehsan and associates
2
in a 14-year-old boy, may be explained by the use of prefixed pericardium as a Norwood patch (in our case) versus pulmonary homograft.
Development of neoaortic valve regurgitation is not uncommon. Under systemic pressure, the structure of pulmonic valves is altered, resulting in worsening incompetence. The pulmonary artery or aortic wall also may be abnormal. The best examples of such dilatation of the aortic or neoaortic root have been observed after either the Ross or Jatene procedure.
3
We assume dilatation and alteration of the sinotubular junction and root may occur in a similar fashion despite the limited data.
4
Several molecular mechanisms have been proposed for aneurysmal dilation from metalloproteinase to alteration in collagen density.
5
Although there was residual neoaortic valve insufficiency after the downsizing of the valve, further long-term studies are needed to determine the role of the aortic root to prevent future aortic annulus dilatation. We recommend that all patients with a neoaortic valve should undergo close follow-up of the aortic root dimensions, in particular to the annulus and sinotubular junction, as we expect neoaortic aneurysm to be detected in more patients in the near future.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |